Found: 10
Select item for more details and to access through your institution.
Targeting Rad51 as a strategy for the treatment of melanoma cells resistant to MAPK pathway inhibition.
- Published in:
- Cell Death & Disease, 2020, v. 11, n. 7, p. 1, doi. 10.1038/s41419-020-2702-y
- By:
- Publication type:
- Article
Melanoma cells resistant towards MAPK inhibitors exhibit reduced TAp73 expression mediating enhanced sensitivity to platinum-based drugs.
- Published in:
- Cell Death & Disease, 2018, v. 9, n. 9, p. 1, doi. 10.1038/s41419-018-0952-8
- By:
- Publication type:
- Article
46th annual congress of the "Arbeitsgemeinschaft Dermatologische Forschung" in Munich, Germany.
- Published in:
- Experimental Dermatology, 2019, v. 28, n. 9, p. 1094, doi. 10.1111/exd.13990
- By:
- Publication type:
- Article
Combined activity of temozolomide and the mTOR inhibitor temsirolimus in metastatic melanoma involves DKK1.
- Published in:
- Experimental Dermatology, 2017, v. 26, n. 7, p. 598, doi. 10.1111/exd.13372
- By:
- Publication type:
- Article
7 Fragen an Dr. Corinna Kosnopfel.
- Published in:
- Kompass Onkologie, 2021, v. 8, n. 2, p. 95, doi. 10.1159/000517069
- By:
- Publication type:
- Article
Single-cell trajectories of melanoma cell resistance to targeted treatment.
- Published in:
- Cancer Biology & Medicine, 2022, v. 19, n. 1, p. 56, doi. 10.20892/j.issn.2095-3941.2021.0267
- By:
- Publication type:
- Article
Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils.
- Published in:
- Cancers, 2024, v. 16, n. 9, p. 1767, doi. 10.3390/cancers16091767
- By:
- Publication type:
- Article
Exploring the In Vitro and In Vivo Therapeutic Potential of BRAF and MEK Inhibitor Combination in NRAS-Mutated Melanoma.
- Published in:
- Cancers, 2023, v. 15, n. 23, p. 5521, doi. 10.3390/cancers15235521
- By:
- Publication type:
- Article
Blood Eosinophils Are Associated with Efficacy of Targeted Therapy in Patients with Advanced Melanoma.
- Published in:
- Cancers, 2022, v. 14, n. 9, p. N.PAG, doi. 10.3390/cancers14092294
- By:
- Publication type:
- Article
Blocking Y-Box Binding Protein-1 through Simultaneous Targeting of PI3K and MAPK in Triple Negative Breast Cancers.
- Published in:
- Cancers, 2020, v. 12, n. 10, p. 2795, doi. 10.3390/cancers12102795
- By:
- Publication type:
- Article